Back
63
Also listed as
OCDDY
OTC
Day Range
$2.61
$3.22
52-Week Range
$2.25
$4.84
Volume
200
50D / 200D Avg
$3.10
/
$3.32
Prev Close
$2.61
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.4 | 10.4 |
| P/B | 1.4 | 1.2 |
| ROE % | 29.5 | 12.3 |
| Net Margin % | 29.3 | 5.3 |
| Rev Growth 5Y % | -13.8 | 5.6 |
| D/E | 1.3 | 0.6 |
Key Takeaways
Revenue declined -13.78% annually over 5 years
ROE of 29.49% indicates high profitability
Net margin of 29.33% shows strong profitability
Generating 152.36M in free cash flow
P/E of 5.36 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 27.43%
Growth
Revenue Growth (5Y)
-13.78%
Revenue (1Y)13.65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
29.49%
ROIC-3.94%
Net Margin29.33%
Op. Margin-13.75%
Safety
Debt / Equity
1.32
Current Ratio2.00
Interest Coverage-1.30
Valuation
P/E Ratio
5.36
P/B Ratio1.39
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.65% | Revenue Growth (3Y) | 10.92% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -13.78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.38B | Net Income (TTM) | 404.83M |
| ROE | 29.49% | ROA | 9.47% |
| Gross Margin | -13.75% | Operating Margin | -13.75% |
| Net Margin | 29.33% | Free Cash Flow (TTM) | 152.36M |
| ROIC | -3.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.32 | Current Ratio | 2.00 |
| Interest Coverage | -1.30 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 5.36 | P/B Ratio | 1.39 |
| P/S Ratio | 1.57 | PEG Ratio | -0.02 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.17B | Enterprise Value | 3.48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.21B | 1.12B | 2.51B | 2.50B |
| Net Income | 404.83M | -336.20M | -314.00M | -455.50M | -223.20M |
| EPS (Diluted) | 0.45 | -0.41 | -0.38 | -0.59 | -0.30 |
| Gross Profit | -189.83M | 1.21B | 98.90M | 964.30M | 932.80M |
| Operating Income | -189.83M | -336.60M | -222.30M | -452.60M | -134.60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.28B | 4.16B | 4.43B | 4.81B | 4.38B |
| Total Liabilities | 2.71B | 2.99B | 2.92B | 2.88B | 2.67B |
| Shareholders' Equity | 1.56B | 1.19B | 1.49B | 1.84B | 1.59B |
| Total Debt | 2.05B | 1.70B | 1.96B | 1.91B | 1.83B |
| Cash & Equivalents | 739.33M | 730.50M | 882.70M | 1.33B | 1.47B |
| Current Assets | 935.36M | 1.57B | 1.44B | 1.77B | 1.89B |
| Current Liabilities | 468.78M | 324.90M | 576.80M | 606.80M | 467.00M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#76 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026